Search - tctmd.com

Displaying 641 - 660 of 713

Sort: Relevancy | Date

News Conference News TCT 2016

Un Nuevo Método para Ablandar la Placa Dura de OTC podría Facilitar las Dificultades de la Intervención

Yael L. Maxwell

November 02, 2016

News Conference News TCT 2016

Novel Method of Softening Hard CTO Plaque May Ease Procedural Difficulties

Yael L. Maxwell

November 02, 2016

News Conference News TCT 2016

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

Michael O'Riordan

November 01, 2016

Presentation TCT 2016

No-Contrast PCI: A Strategy Based on Intravascular Imaging and Physiology to Avoid Contrast-Induced Nephropathy

Presenter: Adrian P. Banning, Ryan D. Madder, Ziad A. Ali

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: ILUMIEN III: OPTIMIZE PCI and COLOR

Presenter: Giulio Guagliumi, Ik-Kyung Jang, Ron Waksman

November 01, 2016

News Industry News TCT 2016

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

November 01, 2016

News Conference News TCT 2016

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

Michael O'Riordan

November 01, 2016

Presentation TCT 2016

Should the Sequence Be: FFR-PCI-OCT? FFR-PCI-IVUS? Just FFR or just IVUS/OCT? And When Is Angiography Enough?

Presenter: Ik-Kyung Jang, Matthew J. Price, Seung-Jung Park

October 31, 2016

Presentation TCT 2016

Imaging Evaluation During PCI: Prediagnostic Value and Post Optimization

Presenter: Seung-Jung Park, Alan C. Yeung, Akiko Maehara

October 31, 2016

Presentation TCT 2016

Outcome-Derived FFR Threshold for Revascularization: Data From the IRIS FFR Registry (N=7,013)

Presenter: Seung-Jung Park, Alan C. Yeung, Jung-Min Ahn

October 31, 2016

Presentation TCT 2016

FFR-Guided Decision Making Is Now Standard

Presenter: Seung-Jung Park, Alan C. Yeung, Nico H.J. Pijls

October 31, 2016

Presentation TCT 2016

Post-PCI FFR Measurements: Lessons From FAME I and II

Presenter: Allen Jeremias, Nico H.J. Pijls, Zsolt Piroth

October 31, 2016

Presentation TCT 2016

OPINION: OCT Follow-Up Substudy from a Randomized Trial of OFDI-Guided PCI vs. IVUS-Guided PCI

Presenter: Joseph A. Hill, Steven P. Marso, Hiromasa Otake

October 31, 2016

Presentation TCT 2016

Case #2: Pre-PCI Assessment of the Distal Left Main Bifurcation With Imaging Both Branches

Presenter: Subhash Banerjee, Akiko Maehara, Jose M. de la Torre Hernandez

October 30, 2016

Presentation TCT 2016

In This Case: iFR Vessel Mapping Was Key to Identify the PCI Target Segment

Presenter: Javier Escaned, Habib Samady, Hitoshi Matsuo

October 30, 2016

Presentation TCT 2016

In This Case: FFR in Complex Multivessel PCI Was Key for Decision-making

Presenter: Javier Escaned, Habib Samady, Keith G. Oldroyd

October 30, 2016

Presentation TCT 2016

ILUMIEN III (OPTIMIZE PCI): A Prospective, Randomized Trial of OCT-Guided vs IVUS-Guided vs Angio-Guided Stent Implantation in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Wayne B. Batchelor, Ziad A. Ali

October 30, 2016

ILUMIEN 3: OCT Imaging Matches IVUS but Fails To Beat Angiography for Stent Guidance in PCI

News Conference News TCT 2016

ILUMIEN III: OCT Imaging Matches IVUS but Fails to Beat Angiography for Stent Guidance in PCI

Shelley Wood

October 30, 2016

News Conference News TCT 2016

YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients

Michael O'Riordan

October 29, 2016

Presentation Stanford Coronary Physiology Conference 2016

Will FFR-Directed PCI Be Better Than CABG? Update on the FAME 3 trial

Presenter: William F. Fearon

October 28, 2016

Advertisement

Un Nuevo Método para Ablandar la Placa Dura de OTC podría Facilitar las Dificultades de la Intervención

Novel Method of Softening Hard CTO Plaque May Ease Procedural Difficulties

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

No-Contrast PCI: A Strategy Based on Intravascular Imaging and Physiology to Avoid Contrast-Induced Nephropathy

Highlights (and my Interpretations) From: ILUMIEN III: OPTIMIZE PCI and COLOR

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

Should the Sequence Be: FFR-PCI-OCT? FFR-PCI-IVUS? Just FFR or just IVUS/OCT? And When Is Angiography Enough?

Imaging Evaluation During PCI: Prediagnostic Value and Post Optimization

Outcome-Derived FFR Threshold for Revascularization: Data From the IRIS FFR Registry (N=7,013)

FFR-Guided Decision Making Is Now Standard

Post-PCI FFR Measurements: Lessons From FAME I and II

OPINION: OCT Follow-Up Substudy from a Randomized Trial of OFDI-Guided PCI vs. IVUS-Guided PCI

Case #2: Pre-PCI Assessment of the Distal Left Main Bifurcation With Imaging Both Branches

In This Case: iFR Vessel Mapping Was Key to Identify the PCI Target Segment

In This Case: FFR in Complex Multivessel PCI Was Key for Decision-making

ILUMIEN III (OPTIMIZE PCI): A Prospective, Randomized Trial of OCT-Guided vs IVUS-Guided vs Angio-Guided Stent Implantation in Patients With Coronary Artery Disease

ILUMIEN III: OCT Imaging Matches IVUS but Fails to Beat Angiography for Stent Guidance in PCI

YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients

Will FFR-Directed PCI Be Better Than CABG? Update on the FAME 3 trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content